Article
Lakeland, Fla. — Molecular staging of melanoma can identify patients with missed micrometastatic disease, offering them the chance to receive more aggressive treatment, thus offering them the best chance of survival.
Dermatology Times November 2024 Print Recap
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Advances in HS treatment with Chris Sayed, MD
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Hydroquinone Pigmentation Alternatives
Polynucleotide Therapy Shows Promise in Scar and Burn Management